Journal
MOLECULES
Volume 26, Issue 17, Pages -Publisher
MDPI
DOI: 10.3390/molecules26175423
Keywords
high-throughput screening; protein-protein interaction; integrated stress response; HIV integration; AlphaLISA; drug repurposing; assay development
Funding
- SIDACTION [AO29-12026]
Ask authors/readers for more resources
Multiple viral targets against HIV infection are available, but therapeutic failures due to resistance highlight the need for alternative antiviral strategies. Recent studies show that phosphorylation of integrase restricts HIV replication and this mechanism is conserved among retroviruses. Developing drugs that target integrase through post-translational modifications could be a promising approach against HIV.
Multiple viral targets are now available in the clinic to fight HIV infection. Even if this targeted therapy is highly effective at suppressing viral replication, caregivers are facing growing therapeutic failures in patients due to resistance, with or without treatment-adherence glitches. Accordingly, it is important to better understand how HIV and other retroviruses replicate in order to propose alternative antiviral strategies. Recent studies have shown that multiple cellular factors are implicated during the integration step and, more specifically, that integrase can be regulated through post-translational modifications. We have shown that integrase is phosphorylated by GCN2, a cellular protein kinase of the integrated stress response, leading to a restriction of HIV replication. In addition, we found that this mechanism is conserved among other retroviruses. Accordingly, we developed an in vitro interaction assay, based on the AlphaLISA technology, to monitor the integrase-GCN2 interaction. From an initial library of 133 FDA-approved molecules, we identified nine compounds that either inhibited or stimulated the interaction between GCN2 and HIV integrase. In vitro characterization of these nine hits validated this pilot screen and demonstrated that the GCN2-integrase interaction could be a viable solution for targeting integrase out of its active site.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available